Expressive Writing Program Among Young Adults With Blood Cancer
ConditionHematologic Malignancy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBlood Cancer United
About this trial
The goal of this study is to learn more about an expressive writing workshop among people with blood cancer. The main question it aims to answer is whether and how an expressive writing workshop can impact mental wellness.
Participants will
* Take part in an online expressive writing workshop for four weeks * Take three surveys at different times over 12 weeks Researchers will compare changes in mental wellness reported by the participants of the workshop to those who will wait four weeks to start the workshop. After four weeks, the participants who are waiting will start their workshop.
Eligibility criteria
Qualifiers
Patient with a hematologic malignancy diagnosis in treatment or after treatment is completed, who is currently between the ages of 18 and 39 (young adult), or the informal caregiver of a young adult blood cancer patient
Located within the U.S., Canada, or U.S. territories
Able to read and write in English
Disqualifiers
Located outside of the U.S., Canada, or its territories
Participant is a minor aged 17 years or below
Trial design
Treatments tested in this trial
- Expressive Writing Workshop
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov